EMAIL THIS PAGE TO A FRIEND

The Journal of biological chemistry

Intramolecular interactions between the Dbl homology (DH) domain and the carboxyl-terminal region of myosin II-interacting guanine nucleotide exchange factor (MyoGEF) act as an autoinhibitory mechanism for the regulation of MyoGEF functions.


PMID 25336641

Abstract

We have reported previously that nonmuscle myosin II-interacting guanine nucleotide exchange factor (MyoGEF) plays an important role in the regulation of cell migration and cytokinesis. Like many other guanine nucleotide exchange factors (GEFs), MyoGEF contains a Dbl homology (DH) domain and a pleckstrin homology domain. In this study, we provide evidence demonstrating that intramolecular interactions between the DH domain (residues 162-351) and the carboxyl-terminal region (501-790) of MyoGEF can inhibit MyoGEF functions. In vitro and in vivo pulldown assays showed that the carboxyl-terminal region (residues 501-790) of MyoGEF could interact with the DH domain but not with the pleckstrin homology domain. Expression of a MyoGEF carboxyl-terminal fragment (residues 501-790) decreased RhoA activation and suppressed actin filament formation in MDA-MB-231 breast cancer cells. Additionally, Matrigel invasion assays showed that exogenous expression of the MyoGEF carboxyl-terminal region decreased the invasion activity of MDA-MB-231 cells. Moreover, coimmunoprecipitation assays showed that phosphorylation of the MyoGEF carboxyl-terminal region by aurora B kinase interfered with the intramolecular interactions of MyoGEF. Furthermore, expression of the MyoGEF carboxyl-terminal region interfered with RhoA localization during cytokinesis and led to an increase in multinucleation. Together, our findings suggest that binding of the carboxyl-terminal region of MyoGEF to its DH domain acts as an autoinhibitory mechanism for the regulation of MyoGEF activation.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C4387
Collagen from bovine achilles tendon, powder, suitable for substrate for collagenase
C7806 Collagen from bovine nasal septum, Bornstein and Traub Type II, powder
C1188 Collagen from bovine tracheal cartilage, Bornstein and Traub Type II, powder
C8919 Collagen from calf skin, Bornstein and Traub Type I, (0.1% solution in 0.1 M acetic acid), aseptically processed, BioReagent, suitable for cell culture
C9791
Collagen from calf skin, Bornstein and Traub Type I, solid, BioReagent, suitable for cell culture
C0543 Collagen from Engelbreth-Holm-Swarm murine sarcoma basement membrane, Type IV (Miller), lyophilized powder (from 0.2 μm-filtered solution), BioReagent, suitable for cell culture
C4407 Collagen from human placenta, Bornstein and Traub Type III (Sigma Type X), powder
C3657 Collagen from human placenta, Bornstein and Traub Type V (Sigma Type IX), powder
C8374
Collagen from human placenta, Bornstein and Traub Type IV, powder
H4417 Collagen from human placenta, Bornstein and Traub Type IV, solution, suitable for cell culture, ≥95% (SDS-PAGE)
C3929 Collagen from kangaroo tail, Bornstein and Traub Type I, powder
C5608 Collagen from rabbit skin, Bornstein and Traub Type I, powder
27666 Collagen from rat tail, for cell biology, soluble
C7624
Collagen human, Bornstein and Traub Type I, recombinant, expressed in Nicotiana tabacum (tobacco)
C7999
Collagen human, Bornstein and Traub Type I, recombinant, expressed in Nicotiana tabacum (tobacco)
C8993 Collagen ovine, aqueous solution
C6745 Collagen Type IV from human cell culture, Bornstein and Traub Type IV, 0.3 mg/mL, sterile-filtered, BioReagent, suitable for cell culture